APAC osteoporosis market will be worth $7.7 billion by 2022; report

The osteoporosis market in the Asia-Pacific (APAC) region, which covers India, China, Australia, South Korea and Japan, will grow from $4.5 billion in 2015 to $7.7 billion in 2022, at a compound annual growth rate of 7.8%.

That is the prediction of a new report by business intelligence provider GBI Research, which states that the factors behind this growth will be the rising prevalence of osteoporosis, better diagnostic techniques, improving awareness, special health care programs for elderly populations and increasing health insurance coverage.

The late-stage osteoporosis pipeline contains promising anabolic and safer antiresorptive therapies that have the potential for approval and launch during the forecast period, the report adds.